Role of ketogenic diets in neurodegenerative diseases (Alzheimer's disease and Parkinson's disease)
Open accessThe DOI matches its Crossref record; 53 of the 53 references it cites were found in a registry or an index.
Abstract
The goal of this review was to assess the effectiveness of ketogenic diets on the therapy of neurodegenerative diseases. The ketogenic diet is a low-carbohydrate and fat-rich diet. Its implementation has a fasting-like effect, which brings the body into a state of ketosis. The ketogenic diet has, for almost 100 years, been used in the therapy of drug-resistant epilepsy, but current studies indicate possible neuroprotective effects. Thus far, only a few studies have evaluated the role of the ketogenic diet in the prevention of Parkinson’s disease (PD) and Alzheimer’s disease (AD). Single studies with human participants have demonstrated a reduction of disease symptoms after application. The application of the ketogenic diet to elderly people, however, raises certain concerns. Persons with neurodegenerative diseases are at risk of malnutrition, while food intake reduction is associated with disease symptoms. In turn, the ketogenic diet leads to a reduced appetite; it is not attractive from an organoleptic point of view, and may be accompanied by side effects of the gastrointestinal system. All this may lead to further lowering of consumed food portions by elderly persons with neurodegenerative diseases and, in consequence, to further reduction in the supply of nutrients provided by the diet. Neither data on the long-term application of the ketogenic diet in patients with neurodegenerative disease or data on its effects on disease symptoms are available. Further research is needed to evaluate the suitability of the ketogenic diet in the therapy of AD- or PD-affected persons.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Moreover, the neuroprotective effects of the ketogenic diet have also been reported in studies, which would benefit patients with Alzheimer’s or Parkinson’s disease [42,43].”
In the citing paper
“Włodarek et al. (106) found that a ketogenic diet, which is high in fat, moderate in protein, and low in carbohydrates, has the potential to reduce neuronal degeneration, and that this specific type of nutritional intervention may provide neuroprotection.”
From Modulation of the gut–brain axis via the gut microbiota: a new era in treatment of amyotrophic lateral sclerosis (2023) · cites this paper as [106]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Tranfield, D., Denyer, D., & Smart, P. (2003) · British Journal of Management · doi:10.1111/1467-8551.00375 · Cited by 15,386 · cited 1×
“The literature’s analyses on the ketogenic diet in the context of neurodegenerative diseases was based on the principles of a structured literature review, a tool used in developing evidence-based knowledge in a rigorous and relevant way [17].”
MethodBauer, J., Biolo, G., Cederholm, T., Cesari, M., Cruz-Jentoft, A. J., Morley, J. E., Phillips, S., Sieber, C., Stehle, P., Teta, D., et al. (2013) · Journal of the American Medical Directors Association · doi:10.1016/j.jamda.2013.05.021 · Cited by 2,553 · cited 1×
“2 g of protein/kg per day, or even more if they are physically active [57].”
BackgroundJasper's Basic Mechanisms of the Epilepsies
(2012) · Oxford University Press eBooks · doi:10.1093/med/9780199746545.001.0001 · Cited by 1,143
Beyond weight loss: a review of the therapeutic uses of very-low-carbohydrate (ketogenic) diets
Paoli, A., Rubini, A., Volek, J. S., & Grimaldi, K. A. (2013) · European Journal of Clinical Nutrition · doi:10.1038/ejcn.2013.116 · Cited by 885 · cited 1×
“In consequence, there is an increased secretion of metabolism nitrogen products, so diuresis in enhanced to maintain a constant dilution of these metabolites in urine [55], while in persons with normal kidney function, it need not exert any negative effects on the body [55].”
BackgroundClinical definition of sarcopenia
Santilli, V (2014) · Clinical Cases in Mineral and Bone Metabolism · doi:10.11138/ccmbm/2014.11.3.177 · Cited by 710 · cited 1×
“Sarcopenia is a problem which affects elderly persons, and its incidence increases with age [56].”
BackgroundThe neuroprotective properties of calorie restriction, the ketogenic diet, and ketone bodies
Maalouf, M., Rho, J. M., & Mattson, M. P. (2009) · Brain Research Reviews · doi:10.1016/j.brainresrev.2008.09.002 · Cited by 574 · cited 1×
“Caloric restriction also has anti-inflammatory effects; it can reduce levels of NFkB, the central component of the inflammatory process, and block the synthesis of interleukins (IL1β, IL2, IL4, IL6) and tumor necrosis factors (TNFα) and suppresses the activity of cyclooxygenase-2 (COX-2) and inducible nitric oxide syn…”
BackgroundHenderson, S. T., Vogel, J. L., Barr, L. J., Garvin, F., Jones, J. J., & Costantini, L. C. (2009) · Nutrition & Metabolism · doi:10.1186/1743-7075-6-31 · Cited by 548 · cited 2×
“A diet based on medium-chain triglycerides (MCT) was applied as a form of therapy in the 1950s [11], which led to an increase in the concentration of ketone bodies in the blood, even if carbohydrates were present in the diet; thus, this version of KD enables the production of ketone bodies without drastic changes in d…”
d -β-Hydroxybutyrate protects neurons in models of Alzheimer's and Parkinson's disease
Kashiwaya, Y., Takeshima, T., Mori, N., Nakashima, K., Clarke, K., & Veech, R. L. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.10.5440 · Cited by 535 · cited 2×
“It was shown that beta-hydroxybutyrate acts in vitro as a neuroprotective agent against the toxicity of MPTP on dopaminergic neurons [7].”
BackgroundManoharan, S., Guillemin, G. J., Abiramasundari, R. S., Essa, M. M., Akbar, M., & Akbar, M. D. (2016) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2016/8590578 · Cited by 523 · cited 1×
“Imbalance in dopamine metabolism due to oxidative stress has been recognized as a contributor to this disease [21].”
BackgroundEffects of β-hydroxybutyrate on cognition in memory-impaired adults
Reger, M. A., Henderson, S. T., Hale, C., Cholerton, B., Baker, L. D., Watson, G. S., Hyde, K., Chapman, D., & Craft, S. (2004) · Neurobiology of Aging · doi:10.1016/s0197-4580(03)00087-3 · Cited by 508
Research works printed but not linked: 4
- Conklin, 1922, Cause and treatment of epilepsy, Jam. Osteopatic. Assoc., 26, 11
- Guelpa, 1911, A lutte contre l’epilepsie par la desintoxication et par la reduction altimentaire, Rev. Ther. Med. Chir. (Paris), 78, 8
- 2012, Characteristisc of ketogenic diet and its terapeutic properties in central nevous system disorders, Annal Academiae Medicea Silesiensis, 66, 66
- Nazarewicz, 2007, Effects of high fat ketogenic diets, Bromat. Chem. Toksykol., XL, 371
Cited by
Lipids and Alzheimer’s Disease
Kao, Y.-C., Ho, P.-C., Tu, Y.-K., Jou, I.-M., & Tsai, K.-J. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21041505 · Cited by 485
“However, KD application for the elderly arouses concerns since people with neurodegenerative diseases have risks of malnutrition and KD might lead to a reduced appetite and be accompanied by gastrointestinal side effects, exacerbating any nutritional deficits [90].”
BackgroundEffects of Ketone Bodies on Brain Metabolism and Function in Neurodegenerative Diseases
Jensen, N. J., Wodschow, H. Z., Nilsson, M., & Rungby, J. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21228767 · Cited by 446
Ketogenic Diet in Alzheimer’s Disease
Rusek, M., Pluta, R., Ułamek-Kozioł, M., & Czuczwar, S. J. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20163892 · Cited by 319
Randomized crossover trial of a modified ketogenic diet in Alzheimer’s disease
Phillips, M. C. L., Deprez, L. M., Mortimer, G. M. N., Murtagh, D. K. J., McCoy, S., Mylchreest, R., Gilbertson, L. J., Clark, K. M., Simpson, P. V., McManus, E. J., et al. (2021) · Alzheimer's Research & Therapy · doi:10.1186/s13195-021-00783-x · Cited by 249
“This proportion is also high given that ketogenic diets are often considered unpalatable [25].”
BackgroundThe Role of Ketogenic Diet in the Treatment of Neurological Diseases
Dyńka, D., Kowalcze, K., & Paziewska, A. (2022) · Nutrients · doi:10.3390/nu14235003 · Cited by 215
Ketogenic diets and chronic disease: weighing the benefits against the risks
Crosby, L., Davis, B., Joshi, S., Jardine, M., Paul, J., Neola, M., & Barnard, N. D. (2021) · Frontiers in Nutrition · doi:10.3389/fnut.2021.702802 · Cited by 229
The Potential Role of Gut Microbiota in Alzheimer’s Disease: From Diagnosis to Treatment
Varesi, A., Pierella, E., Romeo, M., Piccini, G. B., Alfano, C., Bjørklund, G., Oppong, A., Ricevuti, G., Esposito, C., Chirumbolo, S., et al. (2022) · Nutrients · doi:10.3390/nu14030668 · Cited by 225
Chidambaram, S. B., Essa, M. M., Rathipriya, A. G., Bishir, M., Ray, B., Mahalakshmi, A. M., Tousif, A. H., Sakharkar, M. K., Kashyap, R. S., Friedland, R. P., et al. (2022) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2021.107988 · Cited by 204
Mitochondrial dynamics and transport in Alzheimer's disease
Flannery, P. J., & Trushina, E. (2019) · Molecular and Cellular Neuroscience · doi:10.1016/j.mcn.2019.06.009 · Cited by 202
Choi, Y. J., Jeon, S.-M., & Shin, S. (2020) · Nutrients · doi:10.3390/nu12072005 · Cited by 193
“Moreover, the neuroprotective e ff ects of the ketogenic diet have also been reported in studies, which would benefit patients with Alzheimer’s or Parkinson’s disease [42,43].”
BackgroundMicrobiota–Gut–Brain Axis and Epilepsy: A Review on Mechanisms and Potential Therapeutics
Ding, M., Lang, Y., Shu, H., Shao, J., & Cui, L. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.742449 · Cited by 169
Developing dietary interventions as therapy for cancer
Taylor, S. R., Falcone, J. N., Cantley, L. C., & Goncalves, M. D. (2022) · Nature reviews. Cancer · doi:10.1038/s41568-022-00485-y · Cited by 185
Fatty acid metabolism in the progression and resolution of CNS disorders
Bogie, J. F. J., Haidar, M., Kooij, G., & Hendriks, J. J. A. (2020) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2020.01.004 · Cited by 167
The Therapeutic Role of Ketogenic Diet in Neurological Disorders
Pietrzak, D., Kasperek, K., Rękawek, P., & Piątkowska-Chmiel, I. (2022) · Nutrients · doi:10.3390/nu14091952 · Cited by 115
“It appears to play a pivotal role in the pathogenesis of neurodegenerative diseases such as Alzheimer’s disease and Parkinson’s disease [79,80].”
Backgroundβ-hydroxybutyrate as an Anti-Aging Metabolite
Wang, L. Y., Chen, P., & Xiao, W. (2021) · Nutrients · doi:10.3390/nu13103420 · Cited by 143
“β-HB could inhibit abnormal glycolysis and reduce glucose uptake through altering metabolic activity in neurodegeneration [50].”
BackgroundCerovic, M., Forloni, G., & Balducci, C. (2019) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2019.00284 · Cited by 128
Ketogenic Diet: A New Light Shining on Old but Gold Biochemistry
Longo, R., Peri, C., Cricrì, D., Coppi, L., Caruso, D., Mitro, N., Fabiani, E. D., & Crestani, M. (2019) · Nutrients · doi:10.3390/nu11102497 · Cited by 137
“KB also exhibit anti-apoptotic properties and may help in stabilizing the functions of the synapses [99].”
BackgroundJang, J., Kim, S. R., Lee, J. E., Lee, S.-Y., Son, H. J., Choe, W., Yoon, K., Kim, S. S., Yeo, E., & Kang, I. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms25010124 · Cited by 131
Effects of Ketogenic Diet on Neuroinflammation in Neurodegenerative Diseases
Jiang, Z., Yin, X., Wang, M., Chen, T., Wang, Y., Gao, Z., & Wang, Z. (2022) · Aging and Disease · doi:10.14336/ad.2021.1217 · Cited by 127
Global rural health disparities in Alzheimer's disease and related dementias: State of the science
Wiese, L. K., Gibson, A., Guest, M. A., Nelson, A. R., Weaver, R. H., Gupta, A., Carmichael, O. T., Lewis, J., Lindauer, A., Loi, S. M., et al. (2023) · Alzheimer s & Dementia · doi:10.1002/alz.13104 · Cited by 117
Nimbkar, S., Leena, M. M., Moses, J. A., & Anandharamakrishnan, C. (2022) · Comprehensive Reviews in Food Science and Food Safety · doi:10.1111/1541-4337.12926 · Cited by 108
The Role of Diet and Dietary Patterns in Parkinson’s Disease
Knight, E., Geetha, T., Burnett, D. O., & Babu, J. R. (2022) · Nutrients · doi:10.3390/nu14214472 · Cited by 111
“Furthermore, compliance with a KD may be hindered by its associated short- and long-term side effects such as anemia, constipation, cardiomyopathy, decreased appetite, hepatitis, nausea, vomiting, nephrolithiasis, and pancreatitis [94,98].”
BackgroundChatterjee, P., Fernando, M. G., Fernando, B., Dias, C. B., Shah, T. M., Silva, R., Williams, S., Pedrini, S., Hillebrandt, H., Goozee, K. G., et al. (2020) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2020.111209 · Cited by 112
“recent review cited a plethora of studies which have demonstrated neuroprotective and cognitive benefits of MCT- and ketone-rich diets, though cautioned against strict ketogenic diets (Wlodarek, 2019).”
BackgroundInfluentialNapoleão, A., Fernandes, L., Miranda, C., & Marum, A. P. (2021) · Nutrients · doi:10.3390/nu13041302 · Cited by 103
“Further 554 research is needed to evaluate the suitability of the ketogenic diet in this population [79].”
BackgroundInfluentialDiet and lifestyle impact the development and progression of Alzheimer’s dementia
Arora, S., Santiago, J. A., Bernstein, M., & Potashkin, J. A. (2023) · Frontiers in Nutrition · doi:10.3389/fnut.2023.1213223 · Cited by 113
“Nevertheless, more evidence-based research is needed before determining whether adherence to ketogenic diets reduces the risk of dementia (85, 94) and psychiatric diseases (93, 95).”
BackgroundFasting as a Therapy in Neurological Disease
Phillips, M. C. L. (2019) · Nutrients · doi:10.3390/nu11102501 · Cited by 94
Li, R., Liu, Y., Liu, H., & Li, J. (2020) · Journal of Food Biochemistry · doi:10.1111/jfbc.13140 · Cited by 106
Avgerinos, K. I., Egan, J. M., Mattson, M. P., & Kapogiannis, D. (2019) · Ageing Research Reviews · doi:10.1016/j.arr.2019.101001 · Cited by 100
Grammatikopoulou, M. G., Goulis, D. G., Gkiouras, K., Theodoridis, X., Gkouskou, K. K., Evangeliou, A., Dardiotis, E., & Bogdanos, D. P. (2020) · Advances in Nutrition · doi:10.1093/advances/nmaa073 · Cited by 75
“However, adherence to the KD requires drastic changes, and, for this, long-term compliance is challenging to maintain (135).”
BackgroundVinciguerra, F., Graziano, M., Hagnäs, M. P., Frittitta, L., & Tumminia, A. (2020) · Nutrients · doi:10.3390/nu12041019 · Cited by 97
“This anorectic effect could further reduce dietary portions and overall food intake in elderly patients following a KD eating pattern with the subsequent increased risk of malnutrition and deterioration of neurological symptoms [25].”
BackgroundPark, G., Kadyan, S., Hochuli, N., Pollak, J., Wang, B., Salazar, G., Chakrabarty, P., Efron, P. A., Sheffler, J., & Nagpal, R. (2024) · Gut Microbes · doi:10.1080/19490976.2024.2323752 · Cited by 91
Varesi, A., Campagnoli, L. I. M., Fahmideh, F., Pierella, E., Romeo, M., Ricevuti, G., Nicoletta, M., Chirumbolo, S., & Pascale, A. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232012289 · Cited by 88
Ketogenic Diet: An Effective Treatment Approach for Neurodegenerative Diseases
Zhang, H., Tao, Y., & Leng, S. X. (2022) · Current Neuropharmacology · doi:10.2174/1570159x20666220830102628 · Cited by 82
“…main causes of anorexia include reduced secretion of the appetite-stimulating factor neuropeptide Y (NPY) in the hypothalamus, increased chol-ecystokinin secretion to reduce gastric motor function, and increased levels of circulating growth hormone-releasing peptide, which regulates appetite [205].”
InfluentialApproach to the diagnosis and management of dysbiosis
Alagiakrishnan, K., Morgadinho, J., & Halverson, T. (2024) · Frontiers in Nutrition · doi:10.3389/fnut.2024.1330903 · Cited by 91
“Some of the possible complications of this dietary approach can include nausea, vomiting, changes to satiety along with implications to bone mineral density, hepatic function, pancreatic function, blood glucose management, cardiovascular disease risk among other health concerns (226).”
BackgroundDixon, K. A., Michelsen, M. K., & Carpenter, C. L. (2023) · Nutrients · doi:10.3390/nu15030692 · Cited by 83
“The ketogenic diet, also known as keto, was originally coined in the early 20th century as a way to prevent seizures in those with epilepsy [59].”
BackgroundAre ketogenic diets promising for Alzheimer’s disease? A translational review
Lilamand, M., Porte, B., Cognat, E., Hugon, J., Mouton-Liger, F., & Paquet, C. (2020) · Alzheimer's Research & Therapy · doi:10.1186/s13195-020-00615-4 · Cited by 71
Han, F. Y., Conboy-Schmidt, L., Quist‐Rybachuk, G., Volk, H. A., Zanghi, B. M., Pan, Y., & Borges, K. (2021) · Epilepsia · doi:10.1111/epi.16972 · Cited by 80
Lim, J.-M., Letchumanan, V., Tan, L. T., Hong, K., Wong, S. H., Mutalib, N. A., Lee, L., & Law, J. W. (2022) · Nutrients · doi:10.3390/nu14173566 · Cited by 81
Ketogenic Diet: A Review of Composition Diversity, Mechanism of Action and Clinical Application
Malinowska, D., & Żendzian‐Piotrowska, M. (2024) · Journal of Nutrition and Metabolism · doi:10.1155/2024/6666171 · Cited by 82
“In the last decade, there have been an increasing number of results on the efects of the diet on obesity, diabetes, cancer, cardiovascular disease, polycystic ovary syndrome and neurological conditions [9–11, 17, 50, 51].”
BackgroundInfluentialLiu, X., Liu, Y., Liu, J., Zhang, H., Shan, C., Guo, Y., Gong, X., Cui, M., Li, X., & Tang, M. (2023) · Neural Regeneration Research · doi:10.4103/1673-5374.382223 · Cited by 83
“Additionally, one possible explanation for the development of AD is the decrease of probiotic bacteria due to an unbalanced diet (Włodarek, 2019).”
BackgroundLi, J., Maharjan, B., Xie, B., & Tao, C. (2020) · Journal of Medical Internet Research · doi:10.2196/19897 · Cited by 72
“Poor nutrition can increase behavioral symptoms and cause weight loss, and there are many recommendations and guidelines for an ADRD diet [10-13].”
BackgroundKMT2A: Umbrella Gene for Multiple Diseases
Castiglioni, S., Fede, E. D., Bernardelli, C., Lettieri, A., Parodi, C., Grazioli, P., Colombo, E. A., Ancona, S., Milani, D., Ottaviano, E., et al. (2022) · Genes · doi:10.3390/genes13030514 · Cited by 75
Currenti, W., Godos, J., Castellano, S., Mogavero, M. P., Ferri, R., Caraci, F., Grosso, G., & Galvano, F. (2020) · International Journal of Food Sciences and Nutrition · doi:10.1080/09637486.2020.1866504 · Cited by 70
“…levels that are associated with pro-inflammatory state and conversely increases ghrelin and adiponectin levels that have an effect on the stimulation of hippocampal synaptic plasticity and the reduction of inflammation, respectively (Yamauchi et al. 2001; Baatar et al. 2011; Kim et al. 2015).”
BackgroundKetone Bodies Promote Amyloid-β1–40 Clearance in a Human in Vitro Blood–Brain Barrier Model
Versele, R., Corsi, M., Fuso, A., Sevin, E., Businaro, R., Gosselet, F., Fénart, L., & Candela, P. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21030934 · Cited by 68
“During starvation or consumption of a KD, the relative level of glucose in the plasma declines, and that of KBs increases [25,27].”
BackgroundCould very low-calorie ketogenic diets turn off low grade inflammation in obesity? Emerging evidence
Barrea, L., Caprio, M., Watanabe, M., Cammarata, G., Feraco, A., Muscogiuri, G., Verde, L., Colao, A., & Savastano, S. (2022) · Critical Reviews in Food Science and Nutrition · doi:10.1080/10408398.2022.2054935 · Cited by 68
“…outcomes: Standards of Medical Care in Diabetes-2020,” 2020; Muscogiuri et al. 2019; Watanabe, Tozzi, et al. 2020), while others are still emerging, such as neurodegenerative, inflammatory and autoimmune disease (Barrea, Megna, et al. 2022; Choi et al. 2016; Rusek et al. 2019; Włodarek 2019).”
BackgroundKetogenic Diet and Weight Loss: Is There an Effect on Energy Expenditure?
Basolo, A., Magno, S., Santini, F., & Ceccarini, G. (2022) · Nutrients · doi:10.3390/nu14091814 · Cited by 70
Metabolite therapy guided by liquid biopsy proteomics delays retinal neurodegeneration
Wert, K. J., Velez, G., Vijayalakshmi, K., Shankar, V., Evans, L. P., Sengillo, J. D., Zare, R. N., Bassuk, A. G., Tsang, S. H., & Mahajan, V. B. (2020) · EBioMedicine · doi:10.1016/j.ebiom.2020.102636 · Cited by 64
“The ketogenic diet has shown to have neuroprotective effects in the context of several neurodegenerative diseases, such as Alzheimer’s, and Parkinson’s disease [70].”
BackgroundRong, L., Peng, Y., Shen, Q., Chen, K., Fang, B., & Li, W. (2024) · The journal of nutrition health & aging · doi:10.1016/j.jnha.2024.100306 · Cited by 66
“AstudyhasshownthatastrictKDforthe treatment of epilepsy may result in symptoms such as fatigue, headache, nausea, and hypoglycemia [11], and may even lead to adverse reactions including dehydration, hepatitis, pancreatitis, hyperuricemia, hypomag-nesemia, and hyponatremia [50,51].”
Rawat, K., Singh, N., Kumari, P., & Saha, L. (2021) · Reviews in the Neurosciences · doi:10.1515/revneuro-2020-0078 · Cited by 56
The Gut Microbiome–Brain Crosstalk in Neurodegenerative Diseases
Ghezzi, L., Cantoni, C., Rotondo, E., & Galimberti, D. (2022) · Biomedicines · doi:10.3390/biomedicines10071486 · Cited by 57
Winiarska‐Mieczan, A., Baranowska‐Wójcik, E., Kwiecień, M., GRELA, E. R., Szwajgier, D., Kwiatkowska, K., & Kiczorowska, B. (2020) · Nutrients · doi:10.3390/nu12020435 · Cited by 62
The role of nutrition on Parkinson’s disease: a systematic review
Bianchi, V. E., Rizzi, L., & Somaa, F. A. (2022) · Nutritional Neuroscience · doi:10.1080/1028415x.2022.2073107 · Cited by 66
Nutritional Characteristics, Health Impact, and Applications of Kefir
Apalowo, O. E., Adegoye, G. A., Mbogori, T. N., Kandiah, J., & Obuotor, T. M. (2024) · Foods · doi:10.3390/foods13071026 · Cited by 62
Wearable Vertical Graphene-Based Microneedle Biosensor for Real-Time Ketogenic Diet Management
Wang, Q., Liu, Q., Zhong, G., Xu, T., & Zhang, X. (2024) · Analytical Chemistry · doi:10.1021/acs.analchem.4c00960 · Cited by 57
Borsom, E. M., Lee, K., & Cope, E. K. (2020) · Brain Sciences · doi:10.3390/brainsci10110814 · Cited by 61
Targeting Diet and Exercise for Neuroprotection and Neurorecovery in Glaucoma
Tribble, J. R., Hui, F., Jöe, M., Bell, K. C., Chrysostomou, V., Crowston, J. G., & Williams, P. A. (2021) · Cells · doi:10.3390/cells10020295 · Cited by 58
Ketogenic diets and Ketone suplementation: A strategy for therapeutic intervention
Saris, C. G. J., & Timmers, S. (2022) · Frontiers in Nutrition · doi:10.3389/fnut.2022.947567 · Cited by 52
“Hence, it is plausible that caloric restriction is already sufficient for neuroprotection (123, 124).”
BackgroundMonda, A., Torre, M. E. L., Messina, A., Maio, G. D., Monda, V., Moscatelli, F., Stefano, M. D., Marra, M. L., di Padova, M., Dipace, A., et al. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1425816 · Cited by 51
“…of reactive oxygen species (ROS) and showing a consequent anti-in fl ammatory potential given by the inhibition of the activities of cyclooxygenase-2 (COX-2) and inducible nitric oxide synthase (iNOS), as well as by blocking the synthesis of IL-1 b , IL-2, IL-4, IL-6, TNF a . and NF k B (72, 73).”
BackgroundAlsharairi, N. A. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21249580 · Cited by 54
Muddapu, V. R., & Chakravarthy, V. S. (2021) · Scientific Reports · doi:10.1038/s41598-021-81185-9 · Cited by 54
Crujeiras, A. B., Izquierdo, A. G., Primo, D., Milagro, F. I., Sajoux, I., Jácome, M. A., Fernández‐Quintela, A., Portillo, M. P., Martínez, J. A., Olmos, M. Á. M., et al. (2021) · Clinical Nutrition · doi:10.1016/j.clnu.2021.05.010 · Cited by 50
Diet and medical foods in Parkinson’s disease
Lange, K. W., NAKAMURA, Y., Chen, N., Guo, J., Kanaya, S., Lange, K. M., & Li, S. (2019) · Food Science and Human Wellness · doi:10.1016/j.fshw.2019.03.006 · Cited by 51
Mistry, S., & Eschler, D. C. (2021) · AACE Clinical Case Reports · doi:10.1016/j.aace.2020.11.009 · Cited by 46
Mentzelou, M., Dakanalis, A., Vasios, G. K., Gialeli, M., Papadopoulou, S. Κ., & Giaginis, C. (2023) · Nutrients · doi:10.3390/nu15102270 · Cited by 50
“On the other hand, KD compliance necessitates intense daily adjustments, and, for this purpose, prolonged adherence is difficult and highly demanding to sustain [117].”
BackgroundNutrition to Prevent or Treat Cognitive Impairment in Older Adults: A GRADE Recommendation
Buckinx, F., & Aubertin‐Leheudre, M. (2021) · The Journal of Prevention of Alzheimer s Disease · doi:10.14283/jpad.2020.40 · Cited by 45
“The results of the review performed by Włodarek (2019) indicate that studies with human participants have demonstrated a reduction of AD symptoms after application of a ketogenic diet (22).”
BackgroundKuang, G., Halimitabrizi, M., Edziah, A.-A., Salowe, R., & O’Brien, J. M. (2023) · Frontiers in Physiology · doi:10.3389/fphys.2023.1184060 · Cited by 47
“Increased studies in patient populations would be necessary to assess efficacy in human populations and real-world conditions, which could demonstrate poorer adherence to strict dietary restrictions and raise concerns for inadequate nutrition balance in vulnerable populations (Włodarek, 2019).”
BackgroundAktary, N., Jeong, Y., Oh, S., Shin, Y., Sung, Y., Rahman, M., Santiago, L. R., Choi, J., Song, H. G., Nurkolis, F., et al. (2025) · Frontiers in Pharmacology · doi:10.3389/fphar.2025.1601712 · Cited by 53
Induced Ketosis as a Treatment for Neuroprogressive Disorders: Food for Thought?
Morris, G., Puri, B. K., Carvalho, A. F., Maes, M. H. J., Berk, M., Ruusunen, A. A., & OLIVE, L. S. (2020) · The International Journal of Neuropsychopharmacology · doi:10.1093/ijnp/pyaa008 · Cited by 44
“” The classical KD diet, with a very high intake of fatty foods, may produce a range of gastrointestinal side effects such as nausea, vomiting, dehydration, constipation, low appetite, and, most commonly, diarrhea (Włodarek, 2019).”
BackgroundTicinesi, A., Mancabelli, L., Carnevali, L., Nouvenne, A., Meschi, T., Rio, D. D., Ventura, M., Sgoifo, A., & Angelino, D. (2022) · Journal of Alzheimer s Disease · doi:10.3233/jad-215493 · Cited by 44
“…in vitro and animal studies, mainly on the effects of ketones on the mitochondria and their cellular energy-related functions, there still is a lack of clinical studies, as well as a low quality of evidence from the few running ones, to recommend these diets for the prevention of dementia [21, 22].”
Ketone bodies mediate alterations in brain energy metabolism and biomarkers of Alzheimer’s disease
Ramezani, M., Fernando, M. G., Eslick, S., Asih, P. R., Shadfar, S., Bandara, E. M. S., Hillebrandt, H., Meghwar, S., Shahriari, M., Chatterjee, P., et al. (2023) · Frontiers in Neuroscience · doi:10.3389/fnins.2023.1297984 · Cited by 43
“Similar to fasting, MCT-and any kind of ketone-rich diet induce nutritional ketosis (Włodarek, 2019).”
BackgroundMakievskaya, C. I., Popkov, V. A., Andrianova, N. V., Liao, X., Zorov, D. B., & Plotnikov, E. Y. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24032576 · Cited by 41
Low-Carbohydrate High-Fat Diet: A SWOC Analysis
Nuwaylati, D. A., Eldakhakhny, B. M., Bima, A. I. H., Sakr, H. F., & Elsamanoudy, A. Z. (2022) · Metabolites · doi:10.3390/metabo12111126 · Cited by 42
Bjørklund, G., Dadar, M., Anderson, G., Chirumbolo, S., & Maes, M. H. J. (2020) · Pharmacological Research · doi:10.1016/j.phrs.2020.105065 · Cited by 42
Hong, D., Zhang, C., Wu, W., Lu, X., & Zhang, L. (2023) · Frontiers in Neurology · doi:10.3389/fneur.2023.1133546 · Cited by 38
Late-onset unexplained epilepsy: What are we missing?
Sarkis, R. A., Willment, K., Pennell, P. B., & Marshall, G. A. (2019) · Epilepsy & Behavior · doi:10.1016/j.yebeh.2019.106478 · Cited by 39
Prevalence and Risk Factors for Malnutrition in Patients With Parkinson's Disease
Yang, T., Zhan, Z., Zhang, L., Zhu, J., Liu, Y., Zhang, L., Ge, J., Zhao, Y. R., Zhang, L., & Dong, J. (2020) · Frontiers in Neurology · doi:10.3389/fneur.2020.533731 · Cited by 38
Red meat (beef and sheep) products for an ageing population: a review
Holman, B. W. B., Fowler, S. M., & Hopkins, D. L. (2019) · International Journal of Food Science & Technology · doi:10.1111/ijfs.14443 · Cited by 40
Lilamand, M., Mouton‐Liger, F., Valentin, E. D., Ortiz, M. S., & Paquet, C. (2022) · Frontiers in Nutrition · doi:10.3389/fnut.2021.807970 · Cited by 39
“Longer-term effects may lead to anemia, low bone mineral density, nephrolithiasis or cardiomyopathy (36).”
BackgroundOral and intestinal dysbiosis in Parkinson's disease
Berthouzoz, E., Lazarević, V., Zekeridou, A., Jiménez, M. C., Debove, I., Aybek, S., Schrenzel, J., Burkhard, P. R., & Fleury, V. (2023) · Revue Neurologique · doi:10.1016/j.neurol.2022.12.010 · Cited by 40
Tidman, M. M., White, D. R., & White, T. A. (2024) · Neurodegenerative Disease Management · doi:10.1080/17582024.2024.2352394 · Cited by 38
Impact of the Ketogenic Diet on Neurological Diseases: A Review
Rubio, C., López-Landa, A., Parra, H. R., & Rubio‐Osornio, M. (2025) · Life · doi:10.3390/life15010071 · Cited by 39
“Recently, benefits have also been reported for neurological diseases characterized by chronic neuroinflammation [9–13], such as epilepsy [14], Alzheimer’s disease (AD), Parkinson’s disease, traumatic brain injury, cerebral ischemia, multiple sclerosis (MS), Huntington’s disease (HD) [15], and brain…”
Tan, L. Y., Yeo, X. Y., Bae, H., Lee, D. P. S., Ho, R., Kim, J. E., Jo, D., & Jung, S. (2021) · Life · doi:10.3390/life11070698 · Cited by 36
Identification of potential biomarkers for pathogenesis of Alzheimer’s disease
Wang, H., Han, X., & Gao, S. (2021) · Hereditas · doi:10.1186/s41065-021-00187-9 · Cited by 38
“In addition, some genes were significantly enriched in Parkinson disease pathway, which indicated that Parkinson disease and AD might be explored together, as age-related neurodegeneration diseases [42, 43].”
BackgroundNutritional Impact on Metabolic Homeostasis and Brain Health
Carneiro, L., & Pellerin, L. (2022) · Frontiers in Neuroscience · doi:10.3389/fnins.2021.767405 · Cited by 37
“…acids, medium chain triglycerides or other, proteins. . .) are the most documented (Apekey et al., 2009; Kanoski and Davidson, 2011; Paoli, 2014; Sanders, 2014; Vergati et al., 2017; Abdelhamid et al., 2018; Dohrmann et al., 2019; Włodarek, 2019; Carneiro and Leloup, 2020; van Name et al., 2020).”
BackgroundCaminha, M. C., Moreira, A. B., MATHEUS, F. C., Rieger, D. K., Moreira, J. D., Dalmarco, E. M., Demarchi, I. G., & Lin, K. (2021) · Nutrition Reviews · doi:10.1093/nutrit/nuab080 · Cited by 33
Parkinson's disease: the nutrition perspective
Breasail, M. Ó., Smith, M. D., Tenison, E., Henderson, E. J., & Lithander, F. E. (2021) · Proceedings of The Nutrition Society · doi:10.1017/s0029665121003645 · Cited by 36
“There has been speculation that other diets such as the ketogenic, vegetarian and vegan can reduce PD risk although the evidence is limited((96)).”
BackgroundRóg, J., Wingralek, Z. J., Nowak, K., Grudzień, M., Grunwald, A., Banaszek, A., & Karakuła‐Juchnowicz, H. (2024) · Journal of Clinical Medicine · doi:10.3390/jcm13102819 · Cited by 35
Shabbir, I., Liu, K., Riaz, B., Rahim, M. F., Zhong, S., Aweya, J. J., & Cheong, K. (2025) · Nutrients · doi:10.3390/nu17071268 · Cited by 36
Kuter, K. Z., Olech, Ł., Głowacka, U., & Paleczna, M. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22147556 · Cited by 32
“Włodarek [12] reported that on a diet with very low carbohydrate content, glycemia, although decreasing, remains at its physiological level.”
BackgroundChronobiology and Metabolism: Is Ketogenic Diet Able to Influence Circadian Rhythm?
Gangitano, E., Gnessi, L., Lenzi, A., & Ray, D. W. (2021) · Frontiers in Neuroscience · doi:10.3389/fnins.2021.756970 · Cited by 35
“, 2020), cancer (Chung and Park, 2017), neurodegenerative diseases (Wlodarek, 2019) and even COVID-19 (Gangitano et al.”
BackgroundLiśkiewicz, D., Liśkiewicz, A., Nowacka-Chmielewska, M. M., Grabowski, M., Pondel, N., Grabowska, K., Student, S., Barski, J. J., & Małecki, A. (2021) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2021.733607 · Cited by 30
“A large number of studies have demonstrated the neuroprotective properties of the ketogenic diet (reviewed in Yang et al., 2019), but there is still a lot to discover to comprehensively understand the underlying mechanisms.”
BackgroundAmicis, R. S. D., Leone, A., Lessa, C., Foppiani, A., Ravella, S., Ravasenghi, S., Trentani, C., Ferraris, C., Veggiotti, P., GIORGIS, V. D., et al. (2019) · Nutrients · doi:10.3390/nu11081716 · Cited by 31
Ameen, A. O., Freude, K., & Aldana, B. I. (2022) · Biomedicines · doi:10.3390/biomedicines10112778 · Cited by 29
Chaiwiang, N., & Poyomtip, T. (2019) · Acta Microbiologica et Immunologica Hungarica · doi:10.1556/030.66.2019.038 · Cited by 29
Beneficial Effects of the Ketogenic Diet on Nonalcoholic Fatty Liver Disease (NAFLD/MAFLD)
Dyńka, D., Rodzeń, Ł., Rodzeń, M., Łojko, D., Kraszewski, S., Ibrahim, A., Hussey, M., Deptuła, A., Grzywacz, Ż., Ternianov, A., et al. (2024) · Journal of Clinical Medicine · doi:10.3390/jcm13164857 · Cited by 29
“…α ), it inhibits the activity of cyclo-oxygenase-2 (COX-2) and inducible nitric oxide synthase (iNOS), and reduces the level of inflammation-related transcription nuclear factor kappa B (NF κ B) (which plays a key role in the transcription of coding genes inflammation-related proteins) [131–133].”
BackgroundUddin, M. S., Kabir, M. T., Tewari, D., Mamun, A. A., Barreto, G. E., BUNGAU, S. G., Bin-Jumah, M. N., Abdel‐Daim, M. M., & Ashraf, G. M. (2020) · Molecular Neurobiology · doi:10.1007/s12035-020-02065-3 · Cited by 28
Suresh, V. V., Sivaprakasam, S., Bhutia, Y. D., Prasad, P. D., Thangaraju, M., & Ganapathy, V. (2025) · Biomolecules · doi:10.3390/biom15040580 · Cited by 26
Ketotherapeutics for neurodegenerative diseases
Norwitz, N. G., Gilbert‐Jaramillo, J., Clarke, K., & Soto-Mota, A. (2020) · International review of neurobiology · doi:10.1016/bs.irn.2020.02.003 · Cited by 28
“Ketogenic diets have proven to be successful in the treatment of multiple neu- rodegenerative diseases (Vanitallie et al., 2005; Włodarek, 2019), although it is not entirely clear whether the benefits are derived from the ketones themselves or other aspects of the diet.”
The Link Between Nutrition and Alzheimer’s Disease: From Prevention to Treatment
Martins, L. B., Silveira, A. L. M., & Teixeira, A. L. (2021) · Neurodegenerative Disease Management · doi:10.2217/nmt-2020-0023 · Cited by 27
Ortí, J. E. D. L. R., Cuerda‐Ballester, M., Sanchis-Sanchis, C. E., Lajara-Romance, J. M., Navarro-Illana, E., & García-Pardo, M. P. (2023) · Frontiers in Nutrition · doi:10.3389/fnut.2023.1227431 · Cited by 26
Metadata
- Authors
- Włodarek, D.
- Affiliations
- Warsaw University of Life Sciences (PL)
- Corresponding author
- Włodarek, Dariusz
- ORCID
- Włodarek, Dariusz
- Venue
- Nutrients
- Publisher
- MDPI AG
- Published
- 2019-01-15
- Volume
- 11
- Issue
- 1
- Pages
- 169
- ISSN
- 2072-6643 (ISSN-L)
- PMC
- PMC6356942
- OpenAlex
- W2910859275
- Semantic Scholar
- 7d537ea1be5b6de5ff1d316704c5f868eee0291a
- Cited by
- 301
- References
- 53
- Citations by year
- 2026: 14 · 2025: 38 · 2024: 39 · 2023: 46 · 2022: 55 · 2021: 52 · 2020: 40 · 2019: 17
- FWCI
- 4.85
- Type
- journal article
- Language
- en
- Open access
- gold
- dx.doi.org
- Licence
- Locations
- Nutrients (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Topics
- Health Sciences › Medicine › Physiology (medical) › Diet and metabolism studies
- Health Sciences › Medicine › Physiology (medical) › Dietary Effects on Health
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Nutritional Studies and Diet
- Keywords
- ketogenic diet, neurodegenerative diseases, Alzheimer's disease, Parkinson's disease, ketosis, neuroprotection, drug-resistant epilepsy, malnutrition, appetite suppression, gastrointestinal adverse effects, elderly patients, hypophagia
- MeSH terms
- Alzheimer Disease, Appetite, Brain, Feeding Behavior, Humans, Ketosis, Nutritional Status, Parkinson Disease, Malnutrition, Diet, Ketogenic
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.